1. Bert W. O'Malley 美国 Baylor College of Medicine 1993美国医学院院士;1992美国科学院院士 Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by dru..
2. 于金明 中国 山东第一医科大学 中国工程院院士 EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations
3. 曾益新 中国 国家卫生健康委员会 中国科学院院士 Changes in Expression of Multiple Checkpoint Molecules and Infiltration of Tumor Immune Cells after ..
4. 于金明 中国 山东第一医科大学 中国工程院院士 Clinical outcomes of elderly patients (>= 70 years) with resectable esophageal squamous cell carcino..
5. 孙燕 中国 中国医学科学院 中国工程院院士 Icotinib, a selective EGF receptor tyrosine kinase inhibitor, for the treatment of non-small-cell lu..
6. Ken,Shirabe 日本 Gunma University Prognostic value of a modified-immune scoring system in patients with pathological T4 colorectal can..
7. Marcello,Tiseo 意大利 University of Hospital PARMA Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC p..
8. 王洁 中国 中国医学科学院 Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and ..
9. 陈海泉 中国 复旦大学上海医学院 主任医师 Value of adjuvant chemotherapy for patients with pT2N0M0 non-small cell lung cancer receiving radica..
10. Natasha B,Leighl 加拿大 University of Toronto Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung C..
11. Ahn, Sang Hoon 韩国 Yonsei University Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Ak..
12. Jae Hee,Cheon 韩国 Yonsei University Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Ak..
13. Kim, Seung Up 韩国 Yonsei University Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Ak..
14. Nagini, Siddavaram 印度 Annamalai University Crosstalk between PD-L1 and Jak2-Stat3/MAPK-AP1 signaling promotes oral cancer progression, invasion..
15. 杨明 中国 山东第一医科大学 Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistan..
16. Nasser K,Altorki 美国 New York Presbyterian Hospital Regulation of PD-L1 Trafficking from Synthesis to Degradation
17. Timothy E,McGraw 美国 Weill Cornell Medical College Regulation of PD-L1 Trafficking from Synthesis to Degradation
18. Joe Y,Chang 美国 University of Texas MD Anderson Cancer Center Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review a..
19. Michela,Garofalo 英国 University of Manchester Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell pr..
20. David R,Jones 美国 Memorial Sloan-Kettering Cancer Center Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Fact..